Markets

Insider Trading

Hedge Funds

Retirement

Opinion

16 Most Advanced Countries in Medicine

In this article, we list and discuss the 16 Most Advanced Countries in Medicine. If you would like to skip our detailed discussion of the medicine and pharmaceutical industry, you can go directly to 5 Most Advanced Countries in Medicine.

Despite the tragedy of the Pandemic, Covid-19 did successfully revolutionize the medical world. According to the National Library of Medicine, the US government invested at least $31.9 billion in researching, developing, and purchasing mRNA COVID-19 vaccines.

So while the Global Pandemic caused most industries to crash, the pharmaceutical market was one of the obvious exceptions. In fact, it surged the highest during COVID-19. Pfizer Inc (NYSE: PFE), crossed the $100 billion mark in annual revenue. The surge in revenue was due to the massive haul from its COVID-19 products. Its BioNTech-partnered vaccine, Comirnaty, earned $37.8 billion, while its oral antiviral Paxlovid fetched another $18.9 billion in 2022.

Other companies like Cigna Corporation (NYSE: CI), Sanofi (NASDAQ: SNY), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), and Amgen Inc. (NASDAQ: AMGN) also gained substantial growth during the pandemic period, and their stocks remain the top choice for investors in 2024 as well (See: 13 Best Medical Stocks To Invest In).   

Industry Outlook 

Due to its ever-increasing demand, the medicine market has experienced exponential growth over time. In 2001, the pharmaceutical industry was valued at $390 billion, which then grew by 320% in the next (nearly) two decades. In 2019, the industry stood at a valuation of $1.25 trillion, as researched by the National Library of Medicine

After 2019, when the pandemic took the world by surprise, the medicine industry further experienced substantial growth as countries increased their vaccine expenditure. A report by the OECD says that the pharmaceutical industry invested $129 billion in research and development (R&D) in 2021 alone, of which the majority expense was by the US. However, the average OECD health expenditure to GDP ratio declined from the peak of 9.7% that was during the pandemic in 2021 to 9.2% in 2022. 

While further going into depth of the country-level data, countries that spent the most on health in 2022 were the US, Germany, and France, spending 16.6%, 12.7%, and 12.1% of their total GDPs, respectively. 

As far as number of pharmacists go, according to the 2021 OECD report, Japan is the top country with the most practicing pharmacists, with 199 pharmacists per 1000 population. Following Japan — Belgium, and Italy have the most pharmacists — 131 and 128 per 1000 people respectively. 

All in all, the medical world changed drastically post-COVID, and in the next six to seven years, by 2030, new trends and challenges will shape the pharmaceutical industry. For instance, artificial intelligence (AI) will play a crucial role in R&D and will be widely used by companies in various areas of medicine. 

In fact, this aspect of innovation has already started to take shape — Nana Kofi Quakyi, a program manager at the Aurum Institute in Ghana, is currently working to develop an AI model to help healthcare workers prescribe antibiotics without triggering antimicrobial resistance. In his End of Year report, Bill Gates, the former CEO of Microsoft, highlighted Nana’s work and prominent use cases of AI in the medicinal world. Gates Foundation is now looking at how AI tools can address major health issues like AIDs, TB, and Malaria. The National Library of Medicine has further endorsed this development, reporting that AI has emerged successfully as a powerful tool in the medical sector. 

Key players in the pharmaceutical industry, such as Sanofi SA (NASDAQ: SNY), Pfizer Inc (NYSE: PFE), and Janssen Biotech, which is owned by Johnson & Johnson (NYSE: JNJ), have invested in AI to use it for drug discovery and other purposes. 

In 2018, Sanofi SA (NASDAQ: SNY) partnered with Aily Labs and developed an AI platform called “plai.” The app essentially aggregates the company’s internal data and provides an unprecedented 360° view across all its activities. On the other hand, Pfizer Inc (NYSE: PFE), which is currently ranked at the top in the pharma world, used IBM’s supercomputing and AI since 2020 and developed new drugs like PAXLOVID, an oral COVID-19 treatment approved in 2022. Entering 2024, both Sanofi SA (NASDAQ: SNY) and Pfizer Inc (NYSE: PFE) aim to integrate more AI within their operations.

Let’s now move to the list of the top countries in medicine.

16 Most Advanced Countries in Medicine

Our Methodology 

For our list of the most advanced nations in medicine, we’ve ranked them based on three reports. These are the following – Legatum Prosperity Index, 2023, Countries’ Citations in Clinical Medicine, by Institute of Scientific Information, and other credible sources on the internet

Legatum Prosperity Index’s health ‘pillar’ measures the extent to which people have access to essential and advanced healthcare services. The Institute of Scientific Information report, on the other hand, is about the number of citations per paper for countries in the field of clinical medicine. 

Lastly, the CEO-World report is based on a statistical analysis that accounted for factors such as healthcare infrastructure, government readiness, healthcare professionals, and quality of medicine among others. 

We’ve scored these three indexes and then averaged out the scores for the top countries in the three reports. We haven’t considered the countries that did not appear in more than one report. The data for healthcare spending and physicians per 1,000 people in our listed countries comes from the World Bank. The list is presented in ascending order of high scores.

16 Most Advanced Countries in Medicine

16. France

Citations per paper: 8.64

Healthcare Index: 48.27

Legatum-Prosperity Health Score: 80.46

Average: 4.33

Ranked number sixteen, France is known for its rich medical history, having paved the way for modern-day surgeries and chemotherapy. Not only is France recognized for its medical research but also for its healthcare system, which provides universal coverage for residents. In 2023, France spent around 12.1% of its GDP on healthcare which is 1.9% higher than the OECD average. France had 3.2 practicing doctors and 9.7 practicing nurses per 1000 population in 2023. 

15. Austria

Citations per paper: 8.34

Healthcare Index: 54.86

Legatum-Prosperity Health Score: 80.23

Average: 4.33

According to the 2018 Health System Review Report by the Euro Health Observatory, Austria residents have the lowest rate of unmet medical needs in the EU. Apart from healthcare, Austria is also home to several renowned medical schools, including the Vienna School of Medicine. 

There are 5.4 practicing doctors and 10.6 practicing nurses per 1000 people in Austria as of today, according to OECD. The country also has many state-of-the-art hospitals with high-quality equipment like the Vienna General Hospital. Austria is also known to have one of the highest global expenditures on pharmaceuticals and the country spent $7,275 per capita on health in 2023.

14. Belgium

Citations per paper: 11.56

Healthcare Index: 60.16

Legatum-Prosperity Health Score: 80.6

Average: 6.66

Belgium is another medically advanced country, with its medical technology market expected to grow dramatically and reach $4.22 billion in 2024. The country has some of the EU’s best medical universities, like KU Leuven and Ghent University. Austria prioritizes medical research, and Austrian researchers have made notable contributions to fields like immunology and cancer research. In fact, Belgium’s history with immunology goes all the way back to 1919, when Jules Bordet received the first Nobel Prize for his work discoveries within the field.

Belgium also collaborates with renowned international organizations like WHO, which further enhances its standing in the medicine industry. In 2023, Belgium spent 10.9% of its GDP on health and had the 7th highest spending on health expenditures in the world.

13. Denmark

Citations per paper: 12.50

Healthcare Index: 48.54

Legatum-Prosperity Health Score: 81.07

Average: 7

Denmark is considered medically advanced due to its robust healthcare system, excellent medical services, and significant focus on preventative care. It is also one of Europe’s leading medical technology countries, along with Norway, Sweden, and Germany. 

Denmark offers patient-centric services which include online systems where healthcare professionals can access a patient’s data. Denmark has 4.4 practicing doctors and 10.2 practicing nurses per 1000 people as of 2023. According to the International Trades Administration, the Danish digital health market will surpass $1 billion by 2025.

12. Germany

Citations per paper: 7.79 

Healthcare Index: 64.66

Legatum-Prosperity Health Score: 81.41

Average: 7.33

Ranked 12th, Germany has a rich history in the field of medicine and is the birthplace of prominent scientists like Paul Ehrlich and Alfred Bertheim — the inventors of arsphenamine. It is also known for pharmaceutical industry giant Bayer AG (ETR: BAYN) and has the largest healthcare market in the EU. 

Moreover, manufacturing medical technology companies like B.Braun help the medical devices industry grow within the country. By 2028, the medical technology market in Germany is projected to grow by 4.39%. Germany’s solid health infrastructure and focus on research have helped with its advancements in the medical field.

11. USA

Citations per paper: 13.50

Healthcare Index: 56.71

Legatum-Prosperity Health Score: 73.26

Average: 7.33

Despite its expensive healthcare system, the US is considered one of the most medically advanced countries with the second most number of citations per paper. The US is a global leader in the medical field and has some of the best medical research institutions like Harvard and Johns Hopkins. It is at the forefront of medical research, especially in areas like medical technology and Cancer research. The US healthcare costs were $4.7 trillion in 2023 and are expected to grow to $7.3 trillion by 2031.

10. Finland

Citations per paper: 12.62

Healthcare Index: 52.1 

Legatum-Prosperity Health Score: 81.19

Average: 8

Finland is a country that has made major strides in the world of medical research, mainly in the genomics field. It is home to FinnGen, a Finnish biobank, and is one of the world’s leading genomics projects. Finland also has an amazing tax-funded healthcare system and Finnish people are reported to have an 88% satisfaction rate. In 2023, Finland spent $5,599 per capita which is equal to 10.0% of the country’s GDP. Finland also has 3.6 practicing doctors and 18.9 practicing nurses per 1000 people. 

9. Australia

Citations per paper: 9.85

Healthcare Index: 74.11

Legatum-Prosperity Health Score: 80.36

Average: 8.66

Standing at number nine, Australia has one of the best healthcare systems in the world with respect to testing facilities, accessibility, medical care, and healthcare facilities. The country focuses on medical research, especially in the infectious diseases and cancer research fields. In fact, Australia is an international leader in the Cancer research domain and has made significant breakthroughs in the cancer prevention and support domains. The Australian pharmaceutical market played a major role in Covid-19 vaccine development and the market is expected to reach $10.16 billion in 2024.

8. Japan

Citations per paper: 7.53

Healthcare Index: 59.52

Legatum-Prosperity Health Score: 86.5

Average: 8.67

Japan is recognized globally for its contributions to the medical research and technology field, with the country’s medical device market projected to reach $94.23 billion by 2032. The country is known for its innovations in regenerative medicine and robotics. In 2023, Japan spent 11.5% of its GDP on health and is on track to advance even further in the field of medicine in the next few years. The future of medicine in Japan holds robot surgeries and telemedicine, which are currently being launched and regulated. 

7. Israel

Citations per paper: 8.14

Healthcare Index: 61.73

Legatum-Prosperity Health Score: 83.1

Average: 9

Israel is also one of the most advanced countries in medicine as of today. The country spends 7.4% of its GDP on health and has an average of 3.4 practicing doctors per 1000 people. Israel is also home to top research universities like the Tel Aviv University and Weizmann Institute. 

6. Switzerland

Citations per paper: 11.51

Healthcare Index: 59.6

Legatum-Prosperity Health Score: 82.11

Average: 9

Ranked number sixth, Switzerland is known for its world-class hospitals, research institutions, and pharmaceutical companies like Novartis International AG (NYSE: NVS). Swedish researchers have also made significant advancements in molecular biology, genetics, and pharmaceutical development within the last decade. The country provides paid private healthcare insurance to its residents. As of 2024, Switzerland spends 11.3% of its GDP on health which is around $8,049 per capita. There are 4.4 practicing doctors and 18.4 practicing nurses per 1000 people in Switzerland. 

Click to continue reading and see the 5 Most Advanced Countries in Medicine.

Suggested articles:

Disclosure: None. 16 Most Advanced Countries in Medicine is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…